Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations.
Schroeder
T J
TJ
Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, OH 45267-0714.
Hariharan
S
S
First
M R
MR
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001682:Biological Availability; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000276:immunology / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine